Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
SEBI proposes measures to expand resident Indian participation in FPIs
9/08/2025
ICICI Bank, HPCL among 90 stocks with record dates for dividends, splits, bonus next week
9/08/2025
Avoid bottom-fishing in PG Electroplast shares, CDSL among 3 ideas for next week : Rupak De
9/08/2025
Wealth creation boom ahead as India’s growth cycle picks up pace, says Vikas Khemani
9/08/2025
What should fixed income investors do post RBI Monetary Policy Meeting
9/08/2025
NSDL pre-IPO investors finally make money as stock up 62% in 3 days
9/08/2025
